卡介苗接种年龄对全球儿童结核病死亡率的潜在影响:一项建模研究
该建模研究利用152个高负担国家具有全国代表性的住户调查数据估计年龄别卡介苗覆盖率,并校准至2016年全球儿童结核病死亡数。模拟显示,若出生时覆盖率达92%可使15岁前结核病死亡减少5449例(95%不确定性范围218-15071)或2.8%(0.1-7.0);延迟接种则增加死亡,如6周接种即使覆盖率达94%仍增加0.2%(0-0.4)。作者认为应维持并强调世界卫生组织出生时接种卡介苗的推荐。
要点
- 152个高负担国家2016年卡介苗覆盖率估计为1周龄37%、6周龄67%、3岁92%。
- 出生时92%覆盖率可减少全球出生队列15岁前结核病死亡5449例(95%不确定性范围218-15071)。
- 延迟至6周接种即使覆盖率达94%仍增加结核病死亡0.2%(0-0.4)。
核心结论
- 减少延迟并提高出生时覆盖率可大幅降低全球儿童结核病死亡率。
- 模拟中所有延迟至婴儿期后期接种卡介苗的情景均估计会增加结核病死亡,即使覆盖率提高。
- 世界卫生组织出生时接种卡介苗的推荐应予以维持并强调。
研究设计与样本
- 利用152个高负担国家大型全国代表性住户调查数据估计年龄别卡介苗覆盖率,参数化静态数学模型,并校准至2016年全球儿童结核病死亡数。
- 设定12个假设情景,探索出生时、6周、6个月或9-12个月接种卡介苗对全球出生队列15岁前结核病死亡的影响,包括在首剂百白破疫苗(DTP1)或首剂含麻疹成分疫苗(MCV1)接种时接种。
- 假设疫苗效力随年龄恒定,但改变覆盖率和接种延迟程度,包括无延迟。
主要发现
- 152个高负担国家2016年卡介苗覆盖率估计为1周龄37%、6周龄67%、3岁92%。
- 出生时92%覆盖率情景使全球出生队列15岁前结核病死亡减少5449例(95%不确定性范围218-15071)或2.8%(0.1-7.0)。
- 出生时100%覆盖率使结核病死亡减少16.5%(0.7-41.9)。
- 延迟接种增加结核病死亡,例如6周接种(DTP1推荐年龄)使结核病死亡增加0.2%(0-0.4),即使卡介苗达到DTP1覆盖率水平(3岁94%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: BCG has been recommended at birth in countries with a high tuberculosis burden for decades, yet delayed vaccination is widespread. To support a WHO guidance review, we estimated the potential global tuberculosis mortality benefit of administering BCG on time and consequences of later administration. METHODS: We estimated age-specific BCG coverage in 152 high-burden countries using data from large, nationally representative household surveys, to parameterise a static mathematical model, calibrated to global childhood tuberculosis deaths in 2016. 12 hypothetical scenarios explored the effect of BCG delivery at birth, 6 weeks, 6 months, or 9-12 months, on tuberculosis deaths per global birth cohort by age 15 years, including delivery at the time of the first diphtheria-tetanus-pertussis vaccine (DTP1) or the first measles-containing vaccine (MCV1). We assumed constant vaccine efficacy by age, but varied coverage and degree of vaccination delay, including no delay. FINDINGS: In 152 high-burden countries, we estimated that BCG coverage in 2016 was 37% at 1 week of age, 67% at 6 weeks, and 92% at 3 years. Modelled scenarios in which 92% BCG coverage was achieved at birth reduced tuberculosis deaths in the global birth cohort by 5449 (95% uncertainty range 218-15 071) or 2·8% (0·1-7·0) by age 15 years. 100% coverage at birth reduced tuberculosis deaths by 16·5% (0·7-41·9). Later administration increased tuberculosis deaths-eg, BCG vaccination at 6 weeks, the recommended age of DTP1, increased tuberculosis deaths by 0·2% (0-0·4), even if BCG reached DTP1 coverage levels (94% at 3 years). INTERPRETATION: Reducing delays and increasing coverage at birth would substantially reduce global paediatric tuberculosis mortality. Modelled scenarios whereby BCG was administered later in the infant schedule were all estimated to increase tuberculosis deaths, even with increased coverage. The WHO recommendation for BCG at birth should be maintained and emphasised. FUNDING: WHO.
引用
- Roy P, Vekemans J, Clark A, et al. Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling study. Lancet Glob Health. 2019. PMID: 31708146. doi:10.1016/S2214-109X(19)30444-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。